We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Linda Rabeneck

Linda Rabeneck MD, MPH, FRCPC

Professor of Medicine, University of Toronto, Toronto, Ontario, Canada

Dr. Linda Rabeneck, a physician, clinician scientist and health care executive, is Vice President, Prevention and Cancer Control at Ontario Health (Cancer Care Ontario). Dr. Rabeneck is Professor of Medicine and Professor, Dalla Lana School of Public Health at the University of Toronto, as well as Senior Scientist at IC/ES (formerly the Institute for Clinical Evaluative Sciences) in Toronto.

Dr. Rabeneck, whose scholarly work focuses on the evaluation of health care and health system performance, is best-known for her research on colorectal cancer screening. Dr. Rabeneck is the author of over 260 peer-reviewed publications and has made critical research findings that shaped our understanding of the quality and effectiveness of cancer screening. She currently serves as Associate Editor of GASTROENTEROLOGY, from 2013-20 she served as Chair, Colorectal Cancer Screening Committee, World Endoscopy Organization and since 2014 she has served on the Scientific Planning Committee of the International Cancer Screening Network (ICSN). From 2017-19 Dr. Rabeneck served as President, Canadian Academy of Health Sciences.